• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

The Future of ZimVie’s Spine Business Post-Sale: Exploring Potential Alternatives!

January 13, 2024 By SPINEMarketGroup

In a strategic move, ZimVie Inc. recognized globally for its leadership in the dental and spine markets, has finalized a definitive agreement to sell its spine business to H.I.G. Capital, a prominent global alternative investment firm. H.I.G. Capital, a global private equity firm, has a strong track record of successfully managing and growing businesses across various sectors. The $375 million investment underscores their confidence in the future potential and profitability of the spine industry.As the industry awaits the unfolding of this transformative transaction, speculation arises about the potential scenarios and hypotheses that might shape the future of ZimVie’s spine business under the new ownership.The primary objective behind ZimVie’s decision to sell its spine business is to leverage the after-tax proceeds for debt reduction, aligning with the company’s capital allocation priorities. ZimVie aims to position itself as a pure-play dental company in higher-growth end markets by streamlining operations and focusing on its core competency.

This strategic shift raises questions about the fate of its diverse spine portfolio.Given ZimVie’s extensive spine portfolio, including disc prostheses and tethering solutions, there is speculation about the potential for H.I.G. Capital to sell specific segments of the spine business individually. This approach could allow for a more targeted market strategy, capitalizing on the demand for specific spinal innovations. The diverse range of products in ZimVie’s spine division makes this hypothesis intriguing, and the market could witness a strategic sell-off to maximize value.The collaboration between H.I.G. Capital and ZimVie’s spine leadership team could lead to the foundation of a new standalone entity. This specialized medical device company might focus exclusively on spinal innovations, leveraging H.I.G. Capital’s expertise in the medical device space and ZimVie’s established capabilities. 

In conclusion, the strategic sale of ZimVie’s spine business to H.I.G. Capital introduces a myriad of possibilities for the future. Whether through business segmentation, the creation of a new entity, or a collaborative innovation engine, the industry awaits the unfolding narrative of ZimVie’s spine division. 

We would like to know what your opinion is on this topic! Comments are welcome!

Filed Under: ARTICLES, NEWS Tagged With: 2024

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMMED
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
logo paradigm spine
syntropiq logo

POPULAR POST LAST 90 DAYS

  • BROCHURES
  • PRODUCT LIBRARY
  • 2025 Spine Product Launches and Trends: Where is the…
  • Medical Device Correction Addresses Loss of Lordosis…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Medtronic Named in Florida Lawsuit Over Alleged…
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • 2025 Update: Posterior Cervical Spine Systems Market…
  • COMPANIES
  • First CD Horizon™ ModuLeX™ Deformity Surgery in…
  • Top Six Spine Industry Milestones in 2025
  • Globus Medical Reports Preliminary Record Fourth…
  • Seven Leading Augmented (AR) and Extended Reality…
  • The End of an Era: The Former LDR Medical Site in…
  • Medtronic Korea Launches Kanghui, a New…
  • Why Expandable Cages Sometimes Lose Lordosis After…
  • ATEC Announces Select Preliminary Financial Results…
  • Scientists Develop AxioMed Spinal Disc Replacement…
  • LAST 5 VIDEOS PUBLISHED

    1. REVEL™-S: Globus Medical
    2. EXCENDER CG Bio
    3. Spineology: New OptiMesh HA Nano
    4. Taiwan OrthopedicBiotechnology:  Caduceus 
    5. Augmedics: Meet X2

     

     

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup